PubRank

G Feliciangeli

Author PubWeight™ 18.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The Kidney Donor Profile Index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes. Am J Transplant 2014 1.80
2 Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. Gastroenterology 2001 1.57
3 Primary biliary cirrhosis: modalities of injury and death in biliary epithelium. Dig Liver Dis 2001 1.40
4 Validity of flow cytometry for cross-match evaluation in clinical renal transplantation. Nephron 1991 1.38
5 Observer agreement in endoscopic assessment of ulcerative colitis. Ital J Gastroenterol Hepatol 1998 1.02
6 [Health-related quality of life in patients with chronic kidney disease]. G Ital Nefrol 2008 0.88
7 Long-term results: cellulosic vs. synthetic membranes. Contrib Nephrol 1995 0.88
8 Kidney preservation: review of present and future perspective. Transplant Proc 2013 0.85
9 Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006 0.84
10 Intracellular pathways mediating Na+/H+ exchange activation by platelet-derived growth factor in rat hepatic stellate cells. Gastroenterology 1999 0.83
11 Clinical application of sodium profiling in the treatment of intradialytic hypotension. Int J Artif Organs 2003 0.83
12 Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach. Int J Artif Organs 2007 0.83
13 Nephrological indications in combined liver-kidney transplantation. Transplant Proc 2006 0.80
14 Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report. Transplant Proc 2006 0.79
15 Diagnosis of liver fibrosis. Eur Rev Med Pharmacol Sci 2004 0.79
16 Dialysis membrane biocompatibility: effects on cellular elements. Nephrol Dial Transplant 1995 0.78
17 Diagnostic value of endoscopic markers for celiac disease in adults: a multicentre prospective Italian study. Minerva Gastroenterol Dietol 2008 0.77
18 Combined liver-kidney transplantation: the experience of the University of Bologna and the case of preoperative positive cross-match. Transplant Proc 2006 0.77
19 Renal transplant in patients with polycystic disease: the Italian experience. Transplant Proc 2013 0.76
20 [Low-toxicity immunosuppressive therapy in renal transplant]. G Ital Nefrol 2007 0.75
21 [Factors determining cardiovascular disease progression after kidney transplant]. G Ital Nefrol 2009 0.75
22 [Use of a caloric integrator in renal insufficiency]. G Clin Med 1978 0.75
23 Polymorphonucleates activity in dialysis patients treated with different membranes. Life Support Syst 1985 0.75
24 [Protonic pump inhibitors in kidney transplant patients: efficacy and safety]. Minerva Urol Nefrol 2007 0.75
25 Hemoperfusion in chronic uremia. Boll Soc Ital Biol Sper 1993 0.75
26 Evaluation of excebrane by infrared imaging. Contrib Nephrol 1999 0.75
27 Induction therapy with alemtuzumab (campath) in combined liver-kidney transplantation: University of Bologna experience. Transplant Proc 2013 0.75
28 Bionics in renal replacement therapy. Artif Organs 1993 0.75
29 Comparative losses of free amino acids and their plasma variations in artificial substitutive programmes for chronic uraemia. Life Support Syst 1984 0.75
30 [Long-term use of Profiler in patients with dialysis intolerance: 8 months follow-up]. G Ital Nefrol 2005 0.75
31 Digitalis receptors and digoxin sensitivity in renal failure. Clin Exp Pharmacol Physiol 1985 0.75
32 Anticoagulation and platelet activation in hemodialysis: clinical results with PMMA. Contrib Nephrol 1999 0.75
33 [Preventing and reducing comorbidity in candidates for kidney transplantation for the improvement of post-operative results]. G Ital Nefrol 2009 0.75
34 [Continuous ambulatory peritoneal dialysis (CAPD) in the substitutive treatment of chronic renal insufficiency]. G Clin Med 1981 0.75
35 The CMS 08 modulated dialysis. Optimization of dialysis treatment. Contrib Nephrol 1989 0.75
36 Canalicular cholestasis due to amiodarone toxicity. A definite diagnosis obtained by electron microscopy. Ital J Gastroenterol 1996 0.75
37 [Chronic allograft dysfunction: role of immunosuppressive treatment]. G Ital Nefrol 2008 0.75
38 Severe hypertension in chronic renal failure treated with minoxidil. Clin Exp Hypertens 1979 0.75
39 Evaluation of a new coated charcoal for hemoperfusion in uremia. Int J Artif Organs 1979 0.75
40 [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs]. G Ital Nefrol 2009 0.75
41 Combined liver-kidney transplantation--S. Orsola experience: nephrological aspects. Transplant Proc 2006 0.75
42 Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia. Int J Artif Organs 1981 0.75
43 Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study. Nephron 1981 0.75
44 Biotechnology in profiled dialysis. Nephrol Dial Transplant 1996 0.75
45 Incidence of late deep venous thrombosis among renal transplant patients. Transplant Proc 2013 0.75
46 Long-term aspects of blood-material interaction. Life Support Syst 1988 0.75
47 Platelet activation and PDGF-AB release during dialysis. Int J Artif Organs 2002 0.75
48 Tacrolimus-associated myositis: a case report in a renal transplant patient. Transplant Proc 2004 0.75
49 Effects of renal substitutive programs on amino acid patterns in chronic uremia. Kidney Int Suppl 1983 0.75
50 Cellular immunology in regular dialysis: a biological model for biocompatibility evaluation. Nephrol Dial Transplant 1991 0.75
51 Dynamic of a plasma microprotein (lysozyme) in uremic patients on hemodialytic treatment with different membranes. Life Support Syst 1985 0.75
52 Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results. Int J Artif Organs 1986 0.75
53 [Clinical evaluation of living donor]. G Ital Nefrol 2009 0.75
54 Modulated dialysis: a new strategy for the treatment of intradialytic intolerance. Nephrol Dial Transplant 1990 0.75
55 Approach to dialysis biocompatibility: evaluation through in vivo investigation of lymphocyte biology. A technical note. Contrib Nephrol 1993 0.75
56 Shortened treatment time by combined hemodialysis and hemoperfusion. Contrib Nephrol 1985 0.75
57 [Double renal transplant. Retrospective analysis of data on the patient population with double kidney transplantation in the setting of the AIRT]. G Ital Nefrol 2004 0.75
58 [Current status of substitutive therapy with artificial means in chronic renal insufficiency: hemoperfusion and hemofiltration]. G Clin Med 1981 0.75
59 Present status of hemoperfusion/hemodialysis in Italy. Appl Biochem Biotechnol 1984 0.75
60 [The significance of IgM deposits in glomerular nephropathies. Clinico-morphological study]. Minerva Nefrol 1981 0.75
61 Importance of renal mass on graft function outcome after 12 months of cadaveric donor kidney transplantation. Transplant Proc 2010 0.75
62 Functional characteristics of lymphocytes in chronic renal failure: in vitro response to mitogens. Life Support Syst 1983 0.75
63 Donor-specific anti-HLA antibodies after bone-graft transplantation. Impact on a subsequent renal transplantation: a case report. Transplant Proc 2009 0.75
64 [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis]. G Clin Med 1981 0.75
65 Use of combined hemodialysis/hemoperfusion in chronic uremia. Contrib Nephrol 1982 0.75
66 Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996 0.75
67 Treatment of uremic patients with biofiltration: efficacy, biocompatibility and medium-term results. Int J Artif Organs 1986 0.75
68 The new bionic era in renal replacement therapy. Contrib Nephrol 1993 0.75
69 Long-term comparative evaluation of synthetic and cellulosic membranes in dialysis. Int J Artif Organs 1994 0.75
70 Multiple varieties of bionic support in kidney transplantation. Artif Organs 1992 0.75
71 Long term clinical and morphological evaluation of acute renal failure. Adv Exp Med Biol 1987 0.75
72 Regular hemoperfusion in regular dialysis treatment. A long-term study. Int J Artif Organs 1980 0.75
73 Phosphate removal by resin hemoperfusion efficacy and biocompatibility of a new exchange resin. Biomater Artif Cells Immobilization Biotechnol 1992 0.75